SEARCH

SEARCH BY CITATION

References

  • Baek S. J., HorowitZ. J. M. and Eling T. E. (2001) Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene Promoter. J. Biol. Chem. 276, 33 38433 392.
  • Du Q., Melnikova I. N. and Gardner P. D. (1998) Differential effects of heterogeneous nuclear ribonucleoprotein K on Sp1- and Sp3-mediated transcriptional activation of a neuronal nicotinic acetylcholine receptor promoter. J. Biol. Chem. 273, 19 87719 883.
  • Giles K. M., Daly J. M., Beveridge D. J. et al. (2003) The 3′-untranslated region of p21WAF1 mRNA is a composite cis-acting sequence bound by RNA-binding proteins from breast cancer cells, including HuR and poly (C)-binding protein. J. Biol. Chem. 278, 29372946.DOI: 10.1074/jbc.M208439200
  • Guo B., Odgren P. R., Van Wijnen A. J. et al. (1995) The nuclear matrix protein NMP-1 is the transcription factor YY1. Proc. Natl. Acad. Sci. USA. 92, 10 52610 530.
  • Habelhah H., Shah K., Huang L. et al. (2001) ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat. Cell Biol. 3, 325330.
  • Johnson D. R., Levant S. and Bale A. E. (1995) Direct molecular analysis of archival tumor tissue for loss of heterozygosity. Biotechniques 19, 192195.
  • Kieffer B. L. and Evans C. J. (2002) Opioid tolerance- in search of the holy grail. Cell 108, 587590.
  • Kieffer B. L. and Gaveriaux-Ruff C. (2002) Exploring the opioid system by gene knockout. Prog. Neurobio. 66, 285306.
  • Kim C. S., Hwang C. K., Choi H. S. et al. (2004) Neuron-restrictive silencer factor (NRSF) functions as a repressor in neuronal cells to regulate the mu opioid receptor gene. J. Bio. Chem. 279, 46 46446 473.
  • Ko J. L., Minnerath S. R. and Loh H. H. (1997) Dual promoters of mouse mu-opioid receptor gene. Biochem. Biophy. Res. Commun. 234, 351357.
  • Ko J. L., Liu H. C., Minnerath S. R. and Loh H. H. (1998) Transcriptional regulation of mouse mu-opioid receptor gene. J. Biol. Chem. 273, 27 67827 685.
  • Ko J. L. and Loh H. H. (2001) Single-stranded DNA-binding complex involved in transcriptional regulation of mouse mu-opioid receptor gene. J. Biol. Chem. 276, 788795.
  • Ko J. L., Chen H. C. and Loh H. H. (2002) Differential promoter usage of mouse mu-opioid receptor gene during development. Mol. Brain Res. 104, 184193.
  • Ko J. L., Liu H. C. and Loh H. H. (2003) Role of an AP-2-like element in transcriptional regulation of mouse mu-opioid receptor gene. Mol. Brain Res. 112, 153162.
  • Koch T., SchulZ. S., Der Schro¨ H. et al. (1998) Carboxyl-terminal splicing of the rat µ opioid receptor modulates agonist-mediated internalization and receptor resensitization. J. Biol. Chem. 273, 13 65213 657.
  • Korner M., Rattner A., Mauxion F. et al. (1989) A brain-specific transcription activator. Neuron 3, 563572.
  • Kovarik A., Peat N., Wilson D. et al. (1993) Analysis of the tissue-specific promoter of the MUC1 gene. J. Biol. Chem. 268, 99179926.
  • Krecic A. M. and Swanson M. S. (1999) hnRNP complexes: composition, structure, and function. Curr. Opin. Cell Biol. 11, 363371.
  • Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680685.
  • Law P. Y., Wong Y. H. and Loh H. H. (2000) Molecular mechanisms and regulation of opioid receptor signaling. Ann. Rev. Pharmacol. Toxicol. 40, 389430.
  • Lee M., Mori S. and Raychaudhuri P. (1996) trans-Activation by the hnRNP K protein involves an increase in RNA synthesis from the reporter genes. J. Biol. Chem. 271, 34203427.
  • Liang Y. and Carr L. G. (1997) Transcription of the mouse mu-opioid receptor gene is regulated by two promoters. Brain Res. 769, 372374.
  • Liang Y., Mestek A., YuL. et al. (1995) Cloning and characterization of the promoter region of the mouse mu opioid receptor gene. Brain Res. 679, 8288.
  • Mansour A., Fox C. A., Akil H. et al. (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18, 2229.
  • Matunis M. J., Michael W. M. and Dreyfuss G. (1992) Characterization and primary structure of the poly (C)-binding heterogeneous nuclear ribonucleoprotein complex K protein. Mol. Cell. Biol. 12, 164171.
  • Michelotti E. F., Michelotti G. A., Aronsohn A. I. et al. (1996) Heterogeneous nuclear ribonucleoprotein K is a transcription factor. Mol. Cell. Biol. 16, 23502360.
  • Min B. H., Augustin L. B., Felsheim R. F. et al. (1994) Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene. Proc. Natl. Acad. Sci. USA 91, 90819085.
  • Ogata H., Inoue N. and Podolsky D. K. (1998) Identification of a goblet cell-specific enhancer element in the rat intestinal trefoil factor gene promoter bound by a goblet cell nuclear protein. J. Biol. Chem. 273, 30603067.
  • Oosterhuis J. H. and Van Der Hoorn F. A. (1999) Testis-specific TTF-D binds to single-stranded DNA in the c-mos and Odf1 promoters and activates Odf1. J. Biol. Chem. 274, 11 70811 712.
  • Ostareck-Lederer A., Ostareck D. H., Cans C. et al. (2002) c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs. Mol. Cell. Biol. 22, 45354543.
  • Pan Y. X. (2002) Identification and characterization of a novel promoter of the mouse mu opioid receptor gene (Oprm) that generates eight splice variants. Gene 295, 97108.
  • Pan Y. X., Xu J., Mahurter L., Bolan E. et al. (2001) Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc. Natl. Acad. Sci. USA 98, 14 08414 089.
  • Pecorino L. T., Darrow A. L. and Strickland S. (1991) In vitro analysis of the tissue plasminogen activator promoter reveals a GC box-binding activity present in murine brain but undetectable in kidney and liver. Mol. Cell. Biol. 11, 31393147.
  • Riquet F. B., Lujian T., Choy B. K. et al. (2001) YY1 Is a positive regulator of transcription of the Col1a1 gene. J. Biol. Chem. 276, 38 66538 672.
  • Schoenherr C. J. and Anderson D. J. (1995) Silencing is golden: negative regulation in the control of neuronal gene transcription. Current Opinion Neurobio. 5, 566571.
  • Skalweit A., Doller A., Huth A. et al. (2003) Posttranscriptional control of renin synthesis: identification of proteins interacting with renin mRNA-3′-untranslated region. Cir. Res. 92, 419427.
  • Solecki D., SchwarZ. S., Wimmer E. et al. (1997) The promoters for human and monkey poliovirus receptors. Requirements for basic and cell type-specific activity. J. Biol. Chem. 272, 55795586.
  • Sui G., Affar el B., Shi Y. et al. (2004) Yin Yang 1 is a negative regulator of p53. Cell 117, 859872.
  • Takimoto M., Tomonaga T., Matunis M. et al. (1993) Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro. J. Biol. Chem. 268, 18 24918 258.
  • Thisted T., Lyakhov D. L. and Liebhaber S. A. (2001) Optimized RNA targets of two closely related triple KH domain proteins, heterogeneous nuclear ribonucleoprotein K and alphaCP-2KL, suggest Distinct modes of RNA recognition. J. Biol. Chem. 276, 17 48417 496.
  • Tomonaga T. and Levens D. (1995) Heterogeneous nuclear ribonucleoprotein K is a DNA-binding transactivator. J. Biol. Chem. 270, 48754881.
  • Waggoner S. A. and Liebhaber S. A. (2003) Regulation of alpha-globin mRNA stability. Exp. Biol. Med. 228, 387395.